Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

6.6K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.6K
X-Inactivation01:58

X-Inactivation

39.5K
The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
39.5K
Epigenetic Regulation01:46

Epigenetic Regulation

31.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

13.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When double-J stents become a risk: bilateral distal ureteric urothelial carcinoma following ureteric instrumentation: a case report.

BMC urology·2026
Same author

IgG4-Related Retroperitoneal Fibrosis Presenting as Obstructive Acute Kidney Injury: A Case Report.

Cureus·2026
Same author

PneumoMLPred: Innovating pneumonia management with guideline adherence review and explainable machine learning-based mortality prediction - A single-centre retrospective study.

Respiratory medicine·2026
Same author

Assessing hesitancy towards paediatric vaccines among healthcare professionals: A descriptive cross-sectional study from the United Arab Emirates.

Journal of public health research·2025
Same author

Knowledge, Attitudes, and Practices Regarding Analgesic Use Among Adults in the United Arab Emirates: A Cross-Sectional Study.

Cureus·2025
Same author

Evaluation of knowledge, attitudes and vaccine hesitancy towards MMR vaccine among parents in the United Arab Emirates.

PloS one·2025

Related Experiment Video

Updated: Sep 25, 2025

Quick Fluorescent In Situ Hybridization Protocol for Xist RNA Combined with Immunofluorescence of Histone Modification in X-chromosome Inactivation
12:42

Quick Fluorescent In Situ Hybridization Protocol for Xist RNA Combined with Immunofluorescence of Histone Modification in X-chromosome Inactivation

Published on: November 26, 2014

14.1K

XIST in Brain Cancer.

Salma Eldesouki1, Kamel A Samara1, Rama Qadri1

  • 1College of Medicine, University of Sharjah, Sharjah, UAE.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|April 28, 2022
PubMed
Summary

Long non-coding RNAs (lncRNAs) regulate cellular processes. The XIST lncRNA is implicated in brain tumor development and prognosis, affecting key cancer hallmarks like proliferation and chemoresistance.

Keywords:
BiomarkerBrain TumorsGliomasLong non-coding RNAMicrornaPrognosisTumorigenesisXIST

More Related Videos

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome
08:27

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome

Published on: May 22, 2019

6.5K
Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome
11:15

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

Published on: March 2, 2018

7.4K

Related Experiment Videos

Last Updated: Sep 25, 2025

Quick Fluorescent In Situ Hybridization Protocol for Xist RNA Combined with Immunofluorescence of Histone Modification in X-chromosome Inactivation
12:42

Quick Fluorescent In Situ Hybridization Protocol for Xist RNA Combined with Immunofluorescence of Histone Modification in X-chromosome Inactivation

Published on: November 26, 2014

14.1K
A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome
08:27

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome

Published on: May 22, 2019

6.5K
Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome
11:15

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

Published on: March 2, 2018

7.4K

Area of Science:

  • Molecular Biology
  • Genomics
  • Oncology

Background:

  • Long non-coding RNAs (lncRNAs) are abundant in the human genome and regulate gene expression.
  • X-inactive specific transcript (XIST) is a key lncRNA involved in X chromosome inactivation.
  • Emerging evidence links lncRNAs, including XIST, to various pathological conditions, notably cancer.

Purpose of the Study:

  • To review recent advancements in understanding the role of XIST in brain tumor development and prognosis.
  • To explore XIST's involvement in critical cancer hallmarks such as migration, proliferation, angiogenesis, chemoresistance, and apoptosis evasion.
  • To focus on the pathophysiological significance of XIST in gliomas.

Main Methods:

  • Literature review of recent studies on XIST and brain tumors.
  • Analysis of XIST's functional roles in different types of brain neoplasms.
  • Emphasis on experimental and clinical findings related to XIST in gliomas.

Main Results:

  • XIST plays a significant pathophysiological role in brain tumor progression.
  • XIST influences key cellular processes including migration, proliferation, angiogenesis, and chemoresistance.
  • Dysregulation of XIST is associated with the prognosis of various brain tumors, especially gliomas.

Conclusions:

  • XIST is an emerging molecular player in the pathogenesis and progression of brain tumors.
  • Targeting XIST may offer novel therapeutic strategies for brain cancer treatment.
  • Further research into XIST's mechanisms in gliomas is crucial for clinical translation.